메뉴 건너뛰기




Volumn 28, Issue 1, 1998, Pages 13-17

Short duration therapy for Helicobacter pylori in Western Australia: The impact of metronidazole resistance

Author keywords

Helicobacter pylori; Metronidazole resistance; Treatment

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; LANSOPRAZOLE; METRONIDAZOLE; TETRACYCLINE;

EID: 0031910728     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb04452.x     Document Type: Article
Times cited : (20)

References (18)
  • 1
    • 0026521918 scopus 로고
    • Factors influencing the eradication of Helicobacter pylori with triple therapy
    • Graham DY, Lew GM, Malaty HM et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
    • (1992) Gastroenterology , vol.102 , pp. 493-496
    • Graham, D.Y.1    Lew, G.M.2    Malaty, H.M.3
  • 2
    • 0029981650 scopus 로고    scopus 로고
    • Metronidazole resistance: A predictor of failure of Helicobacter pylori eradication by triple therapy
    • Midolo PD, Lambert JR, Turnidge J. Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 1996; 11: 290-2.
    • (1996) J Gastroenterol Hepatol , vol.11 , pp. 290-292
    • Midolo, P.D.1    Lambert, J.R.2    Turnidge, J.3
  • 3
    • 0026669159 scopus 로고
    • Experience with 'triple' anti-Helicobacter pylori eradication therapy: Side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance
    • Bell GD, Powell K, Burridge SM et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Therap 1992; 6: 427-35.
    • (1992) Aliment Pharmacol Therap , vol.6 , pp. 427-435
    • Bell, G.D.1    Powell, K.2    Burridge, S.M.3
  • 5
    • 0028039801 scopus 로고
    • Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial
    • Hosking SW, Ling TKW, Chung SCS et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
    • (1994) Lancet , vol.343 , pp. 508-510
    • Hosking, S.W.1    Ling, T.K.W.2    Chung, S.C.S.3
  • 6
    • 0028851035 scopus 로고
    • Antibacterial treatment of gastric ulcers associated with Helicobacter pylori
    • Sung JJY, Chung SCS, Ling YKW et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
    • (1995) N Engl J Med , vol.332 , pp. 139-142
    • Sung, J.J.Y.1    Chung, S.C.S.2    Ling, Y.K.W.3
  • 7
    • 0030223132 scopus 로고    scopus 로고
    • The MACH 1 study: Optimal one-week treatment for H. pylori defined
    • Lind T, Veldhuyzen van Zanten SJO et al. The MACH 1 study: optimal one-week treatment for H. pylori defined. Helicobacter 1996; 1: 138-44.
    • (1996) Helicobacter , vol.1 , pp. 138-144
    • Lind, T.1    Veldhuyzen Van Zanten, S.J.O.2
  • 10
    • 0001639336 scopus 로고
    • The eradication of Helicobacter pylori in practice: An audit of three years clinical experience with peptic ulcer patients
    • Reilly TG, Roxon V, Watt RP. The eradication of Helicobacter pylori in practice: an audit of three years clinical experience with peptic ulcer patients. Gut 1995; 37 (Suppl): A87.
    • (1995) Gut , vol.37 , Issue.SUPPL.
    • Reilly, T.G.1    Roxon, V.2    Watt, R.P.3
  • 11
    • 0343428801 scopus 로고    scopus 로고
    • Over 95% of patients remain H. pylori negative 6 months after one week low-dose eradication therapy
    • Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. Over 95% of patients remain H. pylori negative 6 months after one week low-dose eradication therapy. Gut 1996; 39 (Suppl): A34.
    • (1996) Gut , vol.39 , Issue.SUPPL.
    • Misiewicz, J.J.1    Harris, A.W.2    Bardhan, K.D.3    Levi, S.4    Langworthy, H.5
  • 12
    • 0023850584 scopus 로고
    • Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis
    • Marshall BJ, Surveyor I. Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis. J Nucl Med 1988; 29: 11-6.
    • (1988) J Nucl Med , vol.29 , pp. 11-16
    • Marshall, B.J.1    Surveyor, I.2
  • 13
    • 0025779232 scopus 로고
    • Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon-14 urea breath test
    • Debongie JC, Pauwels S, Raat A, de Meeus Y, Haot J, Mainguet P. Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon-14 urea breath test. J Nucl Med 1991; 32: 1192-8.
    • (1991) J Nucl Med , vol.32 , pp. 1192-1198
    • Debongie, J.C.1    Pauwels, S.2    Raat, A.3    De Meeus, Y.4    Haot, J.5    Mainguet, P.6
  • 14
    • 15444351206 scopus 로고    scopus 로고
    • Validation of a 10 minute single sample carbon-14-urea breath test for the diagnosis of Helicobacter pylori infection
    • Prabakaran K, Fernandes V, McDonald J, Cortis Jones R. Validation of a 10 minute single sample carbon-14-urea breath test for the diagnosis of Helicobacter pylori infection. ANZ Nucl Med 1996; 27: 24-30.
    • (1996) ANZ Nucl Med , vol.27 , pp. 24-30
    • Prabakaran, K.1    Fernandes, V.2    McDonald, J.3    Cortis Jones, R.4
  • 15
    • 0002972216 scopus 로고
    • Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori
    • Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995; 37 (Suppl): A55.
    • (1995) Gut , vol.37 , Issue.SUPPL.
    • Xia, H.X.1    Buckley, M.2    Hyde, D.3    Keane, C.T.4    O'Morain, C.A.5
  • 16
    • 0042369529 scopus 로고    scopus 로고
    • Influence of H. pylori resistance to antibiotics on eradication outcome
    • Adamek RJ, Suerbam S, Pfaffenbach B, Wegener M, Opferkuch W. Influence of H. pylori resistance to antibiotics on eradication outcome. Gut 1996; 39 (Suppl): A5.
    • (1996) Gut , vol.39 , Issue.SUPPL.
    • Adamek, R.J.1    Suerbam, S.2    Pfaffenbach, B.3    Wegener, M.4    Opferkuch, W.5
  • 17
    • 3142548109 scopus 로고
    • Helicobacter pylori infection and metronidazole resistance in Gloucester
    • Nair P, McNulty CAM, Dent J. Helicobacter pylori infection and metronidazole resistance in Gloucester. Gut 1995; 37 (Suppl): A46.
    • (1995) Gut , vol.37 , Issue.SUPPL.
    • Nair, P.1    McNulty, C.A.M.2    Dent, J.3
  • 18
    • 3142570413 scopus 로고
    • Clinical and endoscopic characteristics of metronidazole resistant Helicobacter pylori
    • Lowy A, Dworkin B, Van Horn K, Schwartz SM, Lebovics E, Bennett Clark S. Clinical and endoscopic characteristics of metronidazole resistant Helicobacter pylori. Gut 1995; 37 (Suppl): A72.
    • (1995) Gut , vol.37 , Issue.SUPPL.
    • Lowy, A.1    Dworkin, B.2    Van Horn, K.3    Schwartz, S.M.4    Lebovics, E.5    Bennett Clark, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.